1649 studies found for:    HCV
Show Display Options
Rank Status Study
1 Completed HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China
Condition: Hepatitis C
Intervention:
2 Completed Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C
Conditions: HCV Infection;   Liver Transplantation
Interventions: Biological: MBL-HCV1;   Other: 0.9% Sodium chloride Placebo
3 Recruiting Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C
Condition: Hepatitis C Infection
Interventions: Biological: MBL-HCV1;   Drug: Telaprevir (Part 1);   Drug: Sofosbuvir (Part 2)
4 Completed Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C
Condition: Healthy
Intervention: Biological: MBL-HCV1
5 Terminated Long Term Vitamin D Therapy in HCV Treated Patients
Condition: Chronic Hepatitis C
Intervention: Drug: Vitamin D
6 Completed Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV
Conditions: Hepatitis C;   HIV Infections
Interventions: Drug: Efavirenz;   Drug: Emtricitabine/Tenofovir disoproxil fumarate
7 Completed Chiron Corp HCV E1/E2 Vaccine
Condition: Hepatitis C
Interventions: Biological: HCV E1E2/MF59;   Drug: Placebo
8 Completed Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients
Condition: Hepatitis C
Intervention:
9 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: PEG-IFNa 2a;   Drug: Ribavirin;   Drug: NUCS
10 Recruiting Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis
Condition: Hepatitis C Virus Infection
Interventions: Drug: Sofosbuvir;   Drug: RBV
11 Not yet recruiting Assessment of Intrahepatic Hepatitis C Virus (HCV) RNA Levels at the Time of Liver Transplantation
Conditions: Hepatitis C Virus;   Liver Transplantation
Intervention:
12 Completed Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients
Condition: Hepatitis C
Intervention: Biological: Ad6NSmut, MVA-NSmut
13 Not yet recruiting SIMpill Medication Dispensing Device in the Treatment of HCV
Condition: Chronic Hepatitis C Virus
Intervention: Device: SIMpill device
14 Active, not recruiting Viral Kinetics in HCV Clearance in Subjects With Hemophilia
Condition: Hepatitis C With Hemophilia
Interventions: Other: Lead -In- PegInterferon + Ribavirin (4 weeks); PegInterferon + Ribavirin + Telaprevir (12 weeks); PegInterferon + Ribavirin (8 weeks);   Other: No Lead-in - No 4-week lead in therapy; PegInterferon + Ribavirin + Telaprevir (12 weeks); PegInterferon+ Ribavirin (12 weeks)
15 Completed
Has Results
Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C
Condition: Hepatitis C
Interventions: Drug: interferon alfa-2b;   Drug: peginterferon alfa-2b;   Drug: ribavirin, USP;   Device: external drug infusion pump
16 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: Nucleoside Reverse Transcriptase Inhibitors;   Drug: PEG-IFNa 2a;   Drug: Ribavirin
17 Completed
Has Results
Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance
Condition: HIV-1 and Hepatitis C Co-Infection
Interventions: Drug: pioglitazone;   Drug: peginterferon;   Drug: ribavirin
18 Recruiting Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection
Condition: Hepatitis C Infection
Intervention: Drug: ITX 5061
19 Not yet recruiting A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV
Condition: Chronic Hepatitis C
Interventions: Drug: Victrelis® (boceprevir) 800mg by mouth, TID (200 mg tablets);   Drug: Peg-Intron® (peginterferon-α-2b), 1.5ug/kg sc injection;   Drug: Rebetol® (ribavirin), 1000/1200mg by mouth daily
20 Recruiting Herpes Simplex Type 1 Suppression in Hepatitis C
Condition: Chronic Hepatitis C Infection
Interventions: Drug: Valacyclovir;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years